# FDA Inspection 1322240 - Galbraith Laboratories Inc - June 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/galbraith-laboratories-inc/4080e79f-f658-4d35-ae2f-7046ba3b9ea2
Source feed: FDA_Inspections

> FDA Inspection 1322240 for Galbraith Laboratories Inc on June 16, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1322240
- Company Name: Galbraith Laboratories Inc
- Inspection Date: 2026-06-16
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Orleans District Office

## Related Documents

- [FDA Inspection 1222900 - 2023-11-16](https://www.keypedia.com/records/fda_inspections/galbraith-laboratories-inc/4cadf4b4-0c80-4dd1-9c4f-9da73da15165)
- [FDA Inspection 1163571 - 2022-03-02](https://www.keypedia.com/records/fda_inspections/galbraith-laboratories-inc/a135ac1d-f253-4053-9753-22f87960aefa)
- [FDA Inspection 993886 - 2016-12-01](https://www.keypedia.com/records/fda_inspections/galbraith-laboratories-inc/f6739a6e-073d-4a52-b558-401a88076de3)
- [FDA Inspection 905657 - 2014-12-03](https://www.keypedia.com/records/fda_inspections/galbraith-laboratories-inc/93e2916a-3bd9-4af6-ae36-c75e5de3b8d4)
- [FDA Inspection 867685 - 2014-02-11](https://www.keypedia.com/records/fda_inspections/galbraith-laboratories-inc/2f730bf0-53d6-4c82-b28e-9c8d6f085dd2)

Company: https://www.keypedia.com/companies/galbraith-laboratories-inc/6a269a6c-2d54-487f-93d9-8939dc052c2d

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea